Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic
Background: The main objective of this research was to analyze whether there were changes in the use of antidepressants, anxiolytics, and hypnotic-sedative drugs, in the context of primary health care, during the COVID-19 pandemic compared to the pre-pandemic period. We further sought to study consu...
| Main Authors: | , , , , , |
|---|---|
| Format: | info:eu-repo/semantics/article |
| Language: | English |
| Published: |
MDPI
2022
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10835/13628 |
| _version_ | 1789408408940576768 |
|---|---|
| author | González-López, María del Carmen Díaz-Calvo, Virginia Ruíz-González, Carlos Nievas Soriano, Bruno José Rebollo-Lavado, Belén Parrón Carreño, Tesifón |
| author_facet | González-López, María del Carmen Díaz-Calvo, Virginia Ruíz-González, Carlos Nievas Soriano, Bruno José Rebollo-Lavado, Belén Parrón Carreño, Tesifón |
| author_sort | González-López, María del Carmen |
| collection | DSpace |
| description | Background: The main objective of this research was to analyze whether there were changes in the use of antidepressants, anxiolytics, and hypnotic-sedative drugs, in the context of primary health care, during the COVID-19 pandemic compared to the pre-pandemic period. We further sought to study consumption in vulnerable population groups. Methods: A cross-sectional observational study was performed in a primary health district of Spain. The data were obtained from the Andalusian Public Health System database, for the pre-COVID-19 period, from March 2019 to February 2020, and for the COVID-19 period, from March 2020 to February 2021. Univariant and bivariant analyses were performed. The effect size was measured using the Rosenthal test. Results: While the total number of medical prescriptions decreased by 2.5% in the COVID-19 period, the prescriptions of psychiatric drugs increased by 6.1%. The increase in the dose consumption per 1000 inhabitants (DHD) was highest for anxiolytics (7.2%), followed by hypnotic-sedatives (5.6%) and antidepressants (3.7%). The consumption of antidepressants, anxiolytics, and sedative-hypnotic drugs was higher in women, older people, and rural areas and lower in areas with social transformation needs, with these differences being statistically significant. Conclusions: The consumption of psychiatric drugs has increased over the COVID-19 pandemic, especially in women, older people, and rural areas. Thus, we should reflect on the adequate use of these drugs. |
| format | info:eu-repo/semantics/article |
| id | oai:repositorio.ual.es:10835-13628 |
| institution | Universidad de Cuenca |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | dspace |
| spelling | oai:repositorio.ual.es:10835-136282023-04-12T19:21:24Z Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic González-López, María del Carmen Díaz-Calvo, Virginia Ruíz-González, Carlos Nievas Soriano, Bruno José Rebollo-Lavado, Belén Parrón Carreño, Tesifón psychiatric drugs primary health care COVID-19 drug consumption drug prescription antidepressants anxiolytics hypnotic-sedatives Background: The main objective of this research was to analyze whether there were changes in the use of antidepressants, anxiolytics, and hypnotic-sedative drugs, in the context of primary health care, during the COVID-19 pandemic compared to the pre-pandemic period. We further sought to study consumption in vulnerable population groups. Methods: A cross-sectional observational study was performed in a primary health district of Spain. The data were obtained from the Andalusian Public Health System database, for the pre-COVID-19 period, from March 2019 to February 2020, and for the COVID-19 period, from March 2020 to February 2021. Univariant and bivariant analyses were performed. The effect size was measured using the Rosenthal test. Results: While the total number of medical prescriptions decreased by 2.5% in the COVID-19 period, the prescriptions of psychiatric drugs increased by 6.1%. The increase in the dose consumption per 1000 inhabitants (DHD) was highest for anxiolytics (7.2%), followed by hypnotic-sedatives (5.6%) and antidepressants (3.7%). The consumption of antidepressants, anxiolytics, and sedative-hypnotic drugs was higher in women, older people, and rural areas and lower in areas with social transformation needs, with these differences being statistically significant. Conclusions: The consumption of psychiatric drugs has increased over the COVID-19 pandemic, especially in women, older people, and rural areas. Thus, we should reflect on the adequate use of these drugs. 2022-04-20T15:47:45Z 2022-04-20T15:47:45Z 2022-04-14 info:eu-repo/semantics/article 1660-4601 http://hdl.handle.net/10835/13628 10.3390/ijerph19084782 en https://www.mdpi.com/1660-4601/19/8/4782 Attribution-NonCommercial-NoDerivatives 4.0 Internacional http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess MDPI |
| spellingShingle | psychiatric drugs primary health care COVID-19 drug consumption drug prescription antidepressants anxiolytics hypnotic-sedatives González-López, María del Carmen Díaz-Calvo, Virginia Ruíz-González, Carlos Nievas Soriano, Bruno José Rebollo-Lavado, Belén Parrón Carreño, Tesifón Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
| title | Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
| title_full | Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
| title_fullStr | Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
| title_full_unstemmed | Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
| title_short | Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
| title_sort | consumption of psychiatric drugs in primary care during the covid-19 pandemic |
| topic | psychiatric drugs primary health care COVID-19 drug consumption drug prescription antidepressants anxiolytics hypnotic-sedatives |
| url | http://hdl.handle.net/10835/13628 |
| work_keys_str_mv | AT gonzalezlopezmariadelcarmen consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic AT diazcalvovirginia consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic AT ruizgonzalezcarlos consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic AT nievassorianobrunojose consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic AT rebollolavadobelen consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic AT parroncarrenotesifon consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic |